Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parasympathetic Augmentation Via Respiratory Training for Patients With Systolic Heart Failure

NCT05223751 is registered in ClinicalTrials.gov with Lancaster General Hospital as lead sponsor.

NCT NCT05223751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05223751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parasympathetic Augmentation Via Respiratory Training for Patients With Systolic Heart Failure
Lead sponsor
Lancaster General Hospital
Phase
Not applicable
Overall status
Terminated
Start date
February 7, 2022
Completion date
September 12, 2025
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diastolic heart failure